The Decree by the Council of Ministers on Pricing of Medicinal
Products for Human Use ("Decree")
entered into effect on 10 July 2015, when it was published in
Official Gazette numbered 29412. It introduces detailed procedures
and principles for establishing, publicizing and changing the
prices of medicinal products for human use in Turkey. The Decree
supersedes the Decree on Pricing of Medicinal Products for Human
Use, which was published in Official Gazette numbered 26568 on 30
A new Communiqué is expected to be issued in accordance
with the new Decree. Until this occurs, provisions of the
Communiqué on Pricing of Medicinal Products for Human Use
issued under the now superseded Decree will continue to apply,
provided they do not contradict the new Decree.
Procedures and principles introduced by the Decree include:
Annual Determination of the
Euro Value: The Price Evaluation Commission will determine
the value of 1 Euro, which will be basis for pricing medicinal
products for human use. The determination must be made within the
first five days of January each year (Article 2(2)). The value of 1
Euro will be 70% of the annual average Euro value, calculated based
on the Central Bank of the Turkish Republic's daily indicative
exchange rate, announced in the previous year's Official
Prices: Companies are responsible for monitoring and
following-up the relevant reference price and for their
declarations to the Ministry of Health (Article 2(1)). The Ministry
of Health will not automatically follow-up the reference price, but
it has the discretion to check declared reference prices.
Declaring Changes to Reference
Prices: Companies must declare changes of reference price
every six months (Article 5). Companies' obligation to declare
reductions in reference prices continue under the Decree.
Profit Rates: Profit
rates of storekeepers and pharmacists indicated under Article 6 of
the Decree will not be applied to medical prices to be purchased
within the scope of alternative reimbursement models in accordance
with Article 73 of the Law of Social Security numbered 5510. The
Price Evaluation Commission can determine medical prices and/or
profit rates without being restricted to the Decree's
Changes: Changes to price lists must be announced each
Friday (or the previous workday, if Friday is public holiday). The
new prices will enter into force the following Tuesday. Voluntary
reductions to the price list will become valid sixty days after the
The Price Evaluation Commission was required to publish the Euro
value to be used until 31 December 2015 within five working days of
the Decree being published in the Gazette (Transitional Article 1).
Accordingly, the Price Evaluation Commission announced the value of
1 Euro to be applied for this period will be TRY 2.0787.
Please see this link for the full text of the new Decree (only
available in Turkish).
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Inquests are something which affect a vast range of NHS and private organisations, as well as individual clinicians, and so we provide a brief overview of recent developments as well as a couple of key potential changes to come.
Le 28 janvier dernier, le Président du Tribunal de grande instance de Nanterre, statuant en référé, a accordé des dommages et intérêts au titre du préjudice d'anxiété à certaines victimes du Mediator dans trois jugements.
The Turkish Competition Board has launched an investigation into the alleged blocking by the Turkish Pharmacists Union of "named patient sales" by pharmaceutical warehouses.
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).